TickerFacts.

Immucell Corp (ICCC): Operating Income

Annual figures by period end, from SEC filings.

$1.65M
Year ended 2025-12-31
$3.87M
Trailing 12 months to 2026-06-30
-2.5%
10-year compound annual growth
$2.12M2009-12-31: -$529.9K2010-12-31: -$690.3K2011-12-31: -$632.7K2012-12-31: $245.0K2013-12-31: -$19.6K2014-12-31: -$206.4K2015-12-31: $2.12M2016-12-31: $890.2K2017-12-31: -$242.8K2018-12-31: -$1.45M2019-12-31: -$953.9K2020-12-31: -$1.38M2021-12-31: $257.4K2022-12-31: -$2.30M2023-12-31: -$5.75M2024-12-31: -$1.64M2025-12-31: $1.65M$1.65M
2009-12-31 Operating Income (USD) 2025-12-31
Period endedOperating IncomeChange YoYSource filing
2025-12-31$1.65Mn/m2026-03-30, From 2025-01-01
2024-12-31-$1.64Mn/m2026-03-30, From 2024-01-01
2023-12-31-$5.75Mn/m2025-03-28, From 2023-01-01
2022-12-31-$2.30Mn/m2024-04-01, From 2022-01-01
2021-12-31$257.4Kn/m2023-03-29, From 2021-01-01
2020-12-31-$1.38Mn/m2022-03-30, From 2020-01-01
2019-12-31-$953.9Kn/m2021-03-30, From 2019-01-01
2018-12-31-$1.45Mn/m2020-03-27, From 2018-01-01
2017-12-31-$242.8Kn/m2019-03-22, From 2017-01-01
2016-12-31$890.2K-58.1%2018-03-29, From 2016-01-01
2015-12-31$2.12Mn/m2017-03-30, From 2015-01-01
2014-12-31-$206.4Kn/m2016-03-25, From 2014-01-01
2013-12-31-$19.6Kn/m2016-03-25, From 2013-01-01
2012-12-31$245.0Kn/m2015-03-26, From 2012-01-01
2011-12-31-$632.7Kn/m2014-03-26, From 2011-01-01
2010-12-31-$690.3Kn/m2013-03-28, From 2010-01-01
2009-12-31-$529.9Kn/a2012-03-27, From 2009-01-01

Operating Income at similar companies

Companies with the same SEC industry code (In Vitro & In Vivo Diagnostic Substances), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedOperating IncomeChange YoY
Immucell Corp (ICCC)2025-12-31$1.65Mn/m
Alpha Teknova, Inc. (TKNO)2025-12-31-$16.98Mn/m
Intellia Therapeutics, Inc. (NTLA)2025-12-31-$440.99Mn/m
Aspira Women's Health Inc. (AWHL)2025-12-31-$7.91Mn/m
Anbio Biotechnology (NNNN)2025-12-31$5.77M+189.1%
Biomerica Inc (BMRA)2026-05-31-$5.32Mn/m
Insight Molecular Diagnostics Inc. (IMDX)2025-12-31-$51.12Mn/m
Volitionrx Ltd (VNRX)2025-12-31-$21.74Mn/m
Celldex Therapeutics, Inc. (CLDX)2025-12-31-$287.37Mn/m

Compare ICCC, TKNO, NTLA, AWHL side by side · Screen every company in In Vitro & In Vivo Diagnostic Substances ↗